Meanwhile, we can also take time to further study the MOA for FL118‐DDX5 interaction and signalling regulation as well as in each of DDX5's downstream targets and their associated signalling network during the development of FL118 into clinical application for cancer treatment. This evidence concerns the gene DDX5 and cancer.